 | • レポートコード：MRC309Z7966 • 出版社/出版日：GlobalInfoResearch / 2023年9月 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| GlobalInfoResearchの最新の調査によると、世界の非経口栄養剤用炭水化物の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。 このレポートは、世界の非経口栄養剤用炭水化物市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。 市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。 本レポートの主な目的は次のとおりです。 - 世界および主要国の市場機会の規模を決定するため - 非経口栄養剤用炭水化物の成長可能性を評価するため - 各製品および最終用途市場の将来の成長を予測するため - 市場に影響を与える競争要因を評価するため 非経口栄養剤用炭水化物市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメント ・ブドウ糖、果糖、転化糖 用途別セグメント ・100ml以下、250ml、500ml、1L以上 主要な市場プレーヤー ・Fresenius Kabi、Baxter、B. Braun、Kelun Pharma、Otsuka Pharmaceutical、Haisco Pharmaceutical Group、King York、Cisen、Lummy Pharmaceutical、Grand Life Sciences、BBCA Pharmaceutical、Biokin Pharmaceutical、Xi'an Libang Pharmaceutical 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、非経口栄養剤用炭水化物製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な非経口栄養剤用炭水化物メーカーの企業概要、2019年～2022年までの非経口栄養剤用炭水化物の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な非経口栄養剤用炭水化物メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2018年～2029年までの地域別非経口栄養剤用炭水化物の販売量、売上、成長性を示しています。 ・第5、6章では、2018年～2029年までの非経口栄養剤用炭水化物の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での非経口栄養剤用炭水化物市場予測を収録しています。 ・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。 ・第13章では、主要な原材料、主要なサプライヤー、および非経口栄養剤用炭水化物の産業チェーンを掲載しています。 ・第14、15章では、非経口栄養剤用炭水化物の販売チャネル、販売業者、顧客、調査結果について説明します。 ***** 目次(一部) ***** ・市場概要 - 非経口栄養剤用炭水化物の概要 - 種類別分析（2018年vs2022年vs2029年）：ブドウ糖、果糖、転化糖 - 用途別分析（2018年vs2022年vs2029年）：100ml以下、250ml、500ml、1L以上 - 世界の非経口栄養剤用炭水化物市場規模・予測 - 世界の非経口栄養剤用炭水化物生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Fresenius Kabi、Baxter、B. Braun、Kelun Pharma、Otsuka Pharmaceutical、Haisco Pharmaceutical Group、King York、Cisen、Lummy Pharmaceutical、Grand Life Sciences、BBCA Pharmaceutical、Biokin Pharmaceutical、Xi'an Libang Pharmaceutical ・メーカー別市場シェア・市場集中度 ・地域別市場分析2018年-2029年 ・種類別分析2018年-2029年：ブドウ糖、果糖、転化糖 ・用途別分析2018年-2029年：100ml以下、250ml、500ml、1L以上 ・非経口栄養剤用炭水化物の北米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・非経口栄養剤用炭水化物のヨーロッパ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・非経口栄養剤用炭水化物のアジア市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・非経口栄養剤用炭水化物の南米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・非経口栄養剤用炭水化物の中東・アフリカ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析） ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
According to our (Global Info Research) latest study, the global Parenteral Nutrition Carbohydrates market size was valued at USD 3215.5 million in 2022 and is forecast to a readjusted size of USD 5422.7 million by 2029 with a CAGR of 7.8% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Parenteral nutrition (PN) is a method of providing essential nutrients, including carbohydrates, directly into the bloodstream through intravenous (IV) infusion. This approach is used when a person is unable to consume adequate nutrients orally or through the gastrointestinal tract.
This report is a detailed and comprehensive analysis for global Parenteral Nutrition Carbohydrates market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Parenteral Nutrition Carbohydrates market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Parenteral Nutrition Carbohydrates market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Parenteral Nutrition Carbohydrates market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Parenteral Nutrition Carbohydrates market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Parenteral Nutrition Carbohydrates
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace.
This report profiles key players in the global Parenteral Nutrition Carbohydrates market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Fresenius Kabi, Baxter, B. Braun, Kelun Pharma and Otsuka Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Parenteral Nutrition Carbohydrates market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Glucose
Fructose
Invert Sugar
Market segment by Application
100ml and Below
250ml
500ml
1L and Above
Major players covered
Fresenius Kabi
Baxter
B. Braun
Kelun Pharma
Otsuka Pharmaceutical
Haisco Pharmaceutical Group
King York
Cisen
Lummy Pharmaceutical
Grand Life Sciences
BBCA Pharmaceutical
Biokin Pharmaceutical
Xi’an Libang Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Parenteral Nutrition Carbohydrates product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Parenteral Nutrition Carbohydrates, with price, sales, revenue and global market share of Parenteral Nutrition Carbohydrates from 2018 to 2023.
Chapter 3, the Parenteral Nutrition Carbohydrates competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Parenteral Nutrition Carbohydrates breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Parenteral Nutrition Carbohydrates market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Parenteral Nutrition Carbohydrates.
Chapter 14 and 15, to describe Parenteral Nutrition Carbohydrates sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Parenteral Nutrition Carbohydrates
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Parenteral Nutrition Carbohydrates Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Glucose
1.3.3 Fructose
1.3.4 Invert Sugar
1.4 Market Analysis by Application
1.4.1 Overview: Global Parenteral Nutrition Carbohydrates Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 100ml and Below
1.4.3 250ml
1.4.4 500ml
1.4.5 1L and Above
1.5 Global Parenteral Nutrition Carbohydrates Market Size & Forecast
1.5.1 Global Parenteral Nutrition Carbohydrates Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Parenteral Nutrition Carbohydrates Sales Quantity (2018-2029)
1.5.3 Global Parenteral Nutrition Carbohydrates Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Fresenius Kabi
2.1.1 Fresenius Kabi Details
2.1.2 Fresenius Kabi Major Business
2.1.3 Fresenius Kabi Parenteral Nutrition Carbohydrates Product and Services
2.1.4 Fresenius Kabi Parenteral Nutrition Carbohydrates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Fresenius Kabi Recent Developments/Updates
2.2 Baxter
2.2.1 Baxter Details
2.2.2 Baxter Major Business
2.2.3 Baxter Parenteral Nutrition Carbohydrates Product and Services
2.2.4 Baxter Parenteral Nutrition Carbohydrates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Baxter Recent Developments/Updates
2.3 B. Braun
2.3.1 B. Braun Details
2.3.2 B. Braun Major Business
2.3.3 B. Braun Parenteral Nutrition Carbohydrates Product and Services
2.3.4 B. Braun Parenteral Nutrition Carbohydrates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 B. Braun Recent Developments/Updates
2.4 Kelun Pharma
2.4.1 Kelun Pharma Details
2.4.2 Kelun Pharma Major Business
2.4.3 Kelun Pharma Parenteral Nutrition Carbohydrates Product and Services
2.4.4 Kelun Pharma Parenteral Nutrition Carbohydrates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Kelun Pharma Recent Developments/Updates
2.5 Otsuka Pharmaceutical
2.5.1 Otsuka Pharmaceutical Details
2.5.2 Otsuka Pharmaceutical Major Business
2.5.3 Otsuka Pharmaceutical Parenteral Nutrition Carbohydrates Product and Services
2.5.4 Otsuka Pharmaceutical Parenteral Nutrition Carbohydrates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Otsuka Pharmaceutical Recent Developments/Updates
2.6 Haisco Pharmaceutical Group
2.6.1 Haisco Pharmaceutical Group Details
2.6.2 Haisco Pharmaceutical Group Major Business
2.6.3 Haisco Pharmaceutical Group Parenteral Nutrition Carbohydrates Product and Services
2.6.4 Haisco Pharmaceutical Group Parenteral Nutrition Carbohydrates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Haisco Pharmaceutical Group Recent Developments/Updates
2.7 King York
2.7.1 King York Details
2.7.2 King York Major Business
2.7.3 King York Parenteral Nutrition Carbohydrates Product and Services
2.7.4 King York Parenteral Nutrition Carbohydrates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 King York Recent Developments/Updates
2.8 Cisen
2.8.1 Cisen Details
2.8.2 Cisen Major Business
2.8.3 Cisen Parenteral Nutrition Carbohydrates Product and Services
2.8.4 Cisen Parenteral Nutrition Carbohydrates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Cisen Recent Developments/Updates
2.9 Lummy Pharmaceutical
2.9.1 Lummy Pharmaceutical Details
2.9.2 Lummy Pharmaceutical Major Business
2.9.3 Lummy Pharmaceutical Parenteral Nutrition Carbohydrates Product and Services
2.9.4 Lummy Pharmaceutical Parenteral Nutrition Carbohydrates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Lummy Pharmaceutical Recent Developments/Updates
2.10 Grand Life Sciences
2.10.1 Grand Life Sciences Details
2.10.2 Grand Life Sciences Major Business
2.10.3 Grand Life Sciences Parenteral Nutrition Carbohydrates Product and Services
2.10.4 Grand Life Sciences Parenteral Nutrition Carbohydrates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Grand Life Sciences Recent Developments/Updates
2.11 BBCA Pharmaceutical
2.11.1 BBCA Pharmaceutical Details
2.11.2 BBCA Pharmaceutical Major Business
2.11.3 BBCA Pharmaceutical Parenteral Nutrition Carbohydrates Product and Services
2.11.4 BBCA Pharmaceutical Parenteral Nutrition Carbohydrates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 BBCA Pharmaceutical Recent Developments/Updates
2.12 Biokin Pharmaceutical
2.12.1 Biokin Pharmaceutical Details
2.12.2 Biokin Pharmaceutical Major Business
2.12.3 Biokin Pharmaceutical Parenteral Nutrition Carbohydrates Product and Services
2.12.4 Biokin Pharmaceutical Parenteral Nutrition Carbohydrates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Biokin Pharmaceutical Recent Developments/Updates
2.13 Xi’an Libang Pharmaceutical
2.13.1 Xi’an Libang Pharmaceutical Details
2.13.2 Xi’an Libang Pharmaceutical Major Business
2.13.3 Xi’an Libang Pharmaceutical Parenteral Nutrition Carbohydrates Product and Services
2.13.4 Xi’an Libang Pharmaceutical Parenteral Nutrition Carbohydrates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Xi’an Libang Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Parenteral Nutrition Carbohydrates by Manufacturer
3.1 Global Parenteral Nutrition Carbohydrates Sales Quantity by Manufacturer (2018-2023)
3.2 Global Parenteral Nutrition Carbohydrates Revenue by Manufacturer (2018-2023)
3.3 Global Parenteral Nutrition Carbohydrates Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Parenteral Nutrition Carbohydrates by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Parenteral Nutrition Carbohydrates Manufacturer Market Share in 2022
3.4.2 Top 6 Parenteral Nutrition Carbohydrates Manufacturer Market Share in 2022
3.5 Parenteral Nutrition Carbohydrates Market: Overall Company Footprint Analysis
3.5.1 Parenteral Nutrition Carbohydrates Market: Region Footprint
3.5.2 Parenteral Nutrition Carbohydrates Market: Company Product Type Footprint
3.5.3 Parenteral Nutrition Carbohydrates Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Parenteral Nutrition Carbohydrates Market Size by Region
4.1.1 Global Parenteral Nutrition Carbohydrates Sales Quantity by Region (2018-2029)
4.1.2 Global Parenteral Nutrition Carbohydrates Consumption Value by Region (2018-2029)
4.1.3 Global Parenteral Nutrition Carbohydrates Average Price by Region (2018-2029)
4.2 North America Parenteral Nutrition Carbohydrates Consumption Value (2018-2029)
4.3 Europe Parenteral Nutrition Carbohydrates Consumption Value (2018-2029)
4.4 Asia-Pacific Parenteral Nutrition Carbohydrates Consumption Value (2018-2029)
4.5 South America Parenteral Nutrition Carbohydrates Consumption Value (2018-2029)
4.6 Middle East and Africa Parenteral Nutrition Carbohydrates Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Parenteral Nutrition Carbohydrates Sales Quantity by Type (2018-2029)
5.2 Global Parenteral Nutrition Carbohydrates Consumption Value by Type (2018-2029)
5.3 Global Parenteral Nutrition Carbohydrates Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Parenteral Nutrition Carbohydrates Sales Quantity by Application (2018-2029)
6.2 Global Parenteral Nutrition Carbohydrates Consumption Value by Application (2018-2029)
6.3 Global Parenteral Nutrition Carbohydrates Average Price by Application (2018-2029)
7 North America
7.1 North America Parenteral Nutrition Carbohydrates Sales Quantity by Type (2018-2029)
7.2 North America Parenteral Nutrition Carbohydrates Sales Quantity by Application (2018-2029)
7.3 North America Parenteral Nutrition Carbohydrates Market Size by Country
7.3.1 North America Parenteral Nutrition Carbohydrates Sales Quantity by Country (2018-2029)
7.3.2 North America Parenteral Nutrition Carbohydrates Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Parenteral Nutrition Carbohydrates Sales Quantity by Type (2018-2029)
8.2 Europe Parenteral Nutrition Carbohydrates Sales Quantity by Application (2018-2029)
8.3 Europe Parenteral Nutrition Carbohydrates Market Size by Country
8.3.1 Europe Parenteral Nutrition Carbohydrates Sales Quantity by Country (2018-2029)
8.3.2 Europe Parenteral Nutrition Carbohydrates Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Parenteral Nutrition Carbohydrates Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Parenteral Nutrition Carbohydrates Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Parenteral Nutrition Carbohydrates Market Size by Region
9.3.1 Asia-Pacific Parenteral Nutrition Carbohydrates Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Parenteral Nutrition Carbohydrates Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Parenteral Nutrition Carbohydrates Sales Quantity by Type (2018-2029)
10.2 South America Parenteral Nutrition Carbohydrates Sales Quantity by Application (2018-2029)
10.3 South America Parenteral Nutrition Carbohydrates Market Size by Country
10.3.1 South America Parenteral Nutrition Carbohydrates Sales Quantity by Country (2018-2029)
10.3.2 South America Parenteral Nutrition Carbohydrates Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Parenteral Nutrition Carbohydrates Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Parenteral Nutrition Carbohydrates Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Parenteral Nutrition Carbohydrates Market Size by Country
11.3.1 Middle East & Africa Parenteral Nutrition Carbohydrates Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Parenteral Nutrition Carbohydrates Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Parenteral Nutrition Carbohydrates Market Drivers
12.2 Parenteral Nutrition Carbohydrates Market Restraints
12.3 Parenteral Nutrition Carbohydrates Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Parenteral Nutrition Carbohydrates and Key Manufacturers
13.2 Manufacturing Costs Percentage of Parenteral Nutrition Carbohydrates
13.3 Parenteral Nutrition Carbohydrates Production Process
13.4 Parenteral Nutrition Carbohydrates Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Parenteral Nutrition Carbohydrates Typical Distributors
14.3 Parenteral Nutrition Carbohydrates Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
